Enable Injections
Manufacturing · Ohio, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
2863 E Sharon Rd, Cincinnati, Ohio, 4524...Phone Number
(513) 326-2800Website
www.enableinjections.comRevenue
$87 MillionIndustry
About Enable Injections
Enable Injections Org Chart
Is Enable Injections your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Enable Injections had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Enable Injections
Product Launch: Get notified when Enable Injections launches new products
Check out if Enable Injections is spiking on competitors!
Earning: See what the market has to say on Enable Injections recently announced quarterly report
Check if Enable Injections has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Enable Injections has new funding data
Enable Injections, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Enable Injections as Masked Content
Find more new buyers
Compare Similar Companies to Enable Injections
Compare insights from companies similar to Enable Injections, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Enable Injections is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Enable Injections is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Enable Injections.
Enable Injections financials insights
Gather financial insights about Enable Injections, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$2M
Multiple Rounds
$60M
Debt
$2M
Series C
$215M
Other Financing Round
$30M
Enable Injections Tech Stack
A closer look at the technologies used by Enable Injections
Most Recent Scoops
Enable Injections News & Media
Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi
Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across Europe Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across EuropeAptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
Digital solution will be designed to help guide users through injection process Digital solution will be designed to help guide users through injection processPress Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myelomaEnable Injections picks up $30M investment from Sanofi - Drug Delivery Business
Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enable Injections
Cincinnati-based Enable Injections is a global healthcare innovation company committed to improving the patient treatment experience through the development and manufacturing of the enFuse® On-Body Delivery System. An innovative wearable technology, the enFuse system is designed to deliver large volumes of pharmaceutical and biologic therapeutics v... Read More
